
Sushant Tyagi
About Sushant Tyagi
Data last updated:
Sushant Tyagi was a Director at Mydoux Technologies Private Limited (2014–2018), Director at Cts Clinical Trial Services India Private Limited (2015–2018) and Director at Ir Innovate Research Private Limited (2014–2018). The companies operate in Information Technology, Healthcare and Pharma.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 03 Dec 2014 | 2014 | ₹2.3 Lakh (FY 2017) | Active | |
| Director | 05 Feb 2015 | 2015 | ₹62 Lakh (FY 2017) | Active | |
| Director | 03 Nov 2014 | 2014 | ₹13.31 Cr (FY 2024) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sushant Tyagi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sushant Tyagi
Sushant Tyagi was first appointed on 03 Nov 2014 as Director at Ir Innovate Research Private Limited. The most recent appointment on record is 05 Feb 2015 at Cts Clinical Trial Services India Private Limited.
Sushant Tyagi held 3 earlier board appointments: Mydoux Technologies Private Limited (Director, 03 Dec 2014 to 14 Sep 2018); Cts Clinical Trial Services India Private Limited (Director, 05 Feb 2015 to 14 Sep 2018); Ir Innovate Research Private Limited (Director, 03 Nov 2014 to 16 Aug 2018).